What are the key compliance requirements for sequence listings under WIPO ST.25?

Key compliance requirements for sequence listings under WIPO ST.25 include:

  • Compliance is not a filing date, 35 U.S.C. 112, 35 U.S.C. 119/120, or per se new matter issue.
  • Compliance can be achieved via amendment.
  • The “Sequence Listing” is an integral part of the application.
  • A replacement “Sequence Listing” must be used for amendments.
  • Angle brackets and numeric identifiers are crucial for the database.
  • Page numbers should only be on PDF or paper versions, not ASCII text files.

As stated in the MPEP: Compliance is not a filing date issue. Compliance is not a 35 U.S.C. 112 issue. Compliance is not a 35 U.S.C. 119 / 120 issue. Compliance is not per se a new matter issue. (MPEP 2429)

To learn more:

Topics: MPEP 2400 - Biotechnology, MPEP 2429 - Helpful Hints For Sequence Rules Compliance Under Wipo St.25, Patent Law, Patent Procedure
Tags: Biotechnology, Compliance, sequence listing, wipo st.25